12-57763698-T-TGGGTGGG
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_StrongPP5_Very_Strong
The NM_000785.4(CYP27B1):c.1319_1325dupCCCACCC(p.Phe443fs) variant causes a frameshift change. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Genomes: 𝑓 0.00017 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
CYP27B1
NM_000785.4 frameshift
NM_000785.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 6.83
Genes affected
CYP27B1 (HGNC:2606): (cytochrome P450 family 27 subfamily B member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the inner mitochondrial membrane where it hydroxylates 25-hydroxyvitamin D3 at the 1alpha position. This reaction synthesizes 1alpha,25-dihydroxyvitamin D3, the active form of vitamin D3, which binds to the vitamin D receptor and regulates calcium metabolism. Thus this enzyme regulates the level of biologically active vitamin D and plays an important role in calcium homeostasis. Mutations in this gene can result in vitamin D-dependent rickets type I. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most 50 bp of the penultimate exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.132 CDS is truncated, and there are 2 pathogenic variants in the truncated region.
PP5
Variant 12-57763698-T-TGGGTGGG is Pathogenic according to our data. Variant chr12-57763698-T-TGGGTGGG is described in ClinVar as [Pathogenic]. Clinvar id is 279798.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CYP27B1 | NM_000785.4 | c.1319_1325dupCCCACCC | p.Phe443fs | frameshift_variant | 8/9 | ENST00000228606.9 | NP_000776.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CYP27B1 | ENST00000228606.9 | c.1319_1325dupCCCACCC | p.Phe443fs | frameshift_variant | 8/9 | 1 | NM_000785.4 | ENSP00000228606.4 | ||
CYP27B1 | ENST00000547344.5 | n.1458_1464dupCCCACCC | non_coding_transcript_exon_variant | 7/8 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00 AC: 26AN: 149740Hom.: 0 Cov.: 32 FAILED QC
GnomAD3 genomes
AF:
AC:
26
AN:
149740
Hom.:
Cov.:
32
FAILED QC
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000223 AC: 56AN: 251182Hom.: 0 AF XY: 0.000162 AC XY: 22AN XY: 135890
GnomAD3 exomes
AF:
AC:
56
AN:
251182
Hom.:
AF XY:
AC XY:
22
AN XY:
135890
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.000213 AC: 298AN: 1400382Hom.: 0 Cov.: 38 AF XY: 0.000190 AC XY: 133AN XY: 699120
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
298
AN:
1400382
Hom.:
Cov.:
38
AF XY:
AC XY:
133
AN XY:
699120
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Data not reliable, filtered out with message: AS_VQSR AF: 0.000174 AC: 26AN: 149854Hom.: 0 Cov.: 32 AF XY: 0.000109 AC XY: 8AN XY: 73186
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
26
AN:
149854
Hom.:
Cov.:
32
AF XY:
AC XY:
8
AN XY:
73186
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:16
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Vitamin D-dependent rickets, type 1A Pathogenic:9
Pathogenic, criteria provided, single submitter | clinical testing | Center for Genomic Medicine, King Faisal Specialist Hospital and Research Center | Dec 18, 2024 | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Dec 01, 1998 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Jul 30, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Mar 28, 2024 | Variant summary: CYP27B1 c.1319_1325dupCCCACCC (p.Phe443ProfsX24) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein. The variant allele was found at a frequency of 0.00022 in 251182 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in CYP27B1 causing Vitamin D-dependent rickets (0.00022 vs 0.0011), allowing no conclusion about variant significance. c.1319_1325dupCCCACCC has been reported in the literature in multiple individuals affected with Vitamin D-dependent rickets (example: Kaygusuz_2021). These data indicate that the variant is very likely to be associated with disease. The following publication has been ascertained in the context of this evaluation (PMID: 33386952). ClinVar contains an entry for this variant (Variation ID: 279798). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Payam Genetics Center, General Welfare Department of North Khorasan Province | Mar 01, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 07, 2023 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Kasturba Medical College, Manipal, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, India | Jan 13, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Jan 03, 2022 | Frameshift: predicted to result in a loss or disruption of normal protein function through protein truncation. Multiple pathogenic variants are reported in the predicted truncated region (PVS1_S). The variant was co-segregated with Vitamin D-dependent rickets, type I in multiple affected family members (PMID: 22443290, PP1_P). The variant has been reported at least twice as pathogenic/likely pathogenic with clinical assertions and evidence for the classification (ClinVar ID: VCV000279798, PMID:9837822). It is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.000209, PM2_M). The variant has been reported to be in trans as homozygous in at least one similarly affected unrelated individual (PMID: 22443290,PM3_P). Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory of Medical Genetics, National & Kapodistrian University of Athens | Nov 04, 2022 | PVS1, PM2, PP5 - |
not provided Pathogenic:4
Pathogenic, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 19, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Apr 05, 2022 | Frameshift variant predicted to result in protein truncation, as the last 66 amino acids are replaced with 23 different amino acids, and other loss-of-function variants have been reported downstream in the Human Gene Mutation Database (HGMD); This variant is associated with the following publications: (PMID: 9837822, 22443290, 28587998, 22588163, 31980526, 25296067, 31589614, 33386952, 33004071, 25284246, 30282619, 33329754) - |
Pathogenic, criteria provided, single submitter | clinical testing | Clinical Genetics Laboratory, Skane University Hospital Lund | Dec 05, 2022 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | This sequence change creates a premature translational stop signal (p.Phe443Profs*24) in the CYP27B1 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 66 amino acid(s) of the CYP27B1 protein. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This premature translational stop signal has been observed in individuals with vitamin D-dependent rickets (PMID: 9837822, 22443290, 25296067). It has also been observed to segregate with disease in related individuals. This variant is also known as c.1325-1326insCCCACCC and 7bpdup. ClinVar contains an entry for this variant (Variation ID: 279798). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 02, 2021 | The c.1319_1325dupCCCACCC (p.F443Pfs*24) alteration, located in coding exon 8 of the CYP27B1 gene, consists of a duplication of 7 nucleotides at position 1319, causing a translational frameshift with a predicted alternate stop codon after 24 amino acids. This alteration occurs at the 3' terminus of the CYP27B1 gene, is not expected to trigger nonsense-mediated mRNA decay, and only impacts the last 12.8% (65/508 amino acids) of the protein. However, premature stop codons are typically deleterious in nature and the impacted region is critical for protein function (Ambry internal data). The p.F443Pfs*24 alteration has been reported in both a homozygous and compound heterozygous state with other alterations in the CYP27B1 gene in several unrelated patients with vitamin D-dependent rickets (Wang, 1998; Durmaz, 2012; Ito, 2014; Dursun, 2019; Li, 2020). Based on the available evidence, this alteration is classified as pathogenic. - |
CYP27B1-related disorder Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Aug 09, 2024 | The CYP27B1 c.1319_1325dup7 variant is predicted to result in a frameshift and premature protein termination (p.Phe443Profs*24). This variant in the compound heterozygous and homozygous conditions was repeatedly reported to be pathogenic for pseudo–vitamin D–deficiency rickets (see example: reported as c.1325-1326insCCCACCC, Ito et al. 2014. PubMed ID: 25296067; Durmaz. 2012. PubMed ID: 22443290). This variant is reported in 0.045% of alleles in individuals of East Asian descent in gnomAD. Frameshift variants in CYP27B1 are expected to be pathogenic. This variant is interpreted as pathogenic. - |
Vitamin D-dependent rickets, type 1 Pathogenic:1
Pathogenic, no assertion criteria provided | clinical testing | Biochemical Molecular Genetic Laboratory, King Abdulaziz Medical City | Feb 05, 2020 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at